These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32335139)

  • 1. Predictors of a good response to inhaled corticosteroids in obesity-associated asthma.
    Peerboom S; Graff S; Seidel L; Paulus V; Henket M; Sanchez C; Guissard F; Moermans C; Louis R; Schleich F
    Biochem Pharmacol; 2020 Sep; 179():113994. PubMed ID: 32335139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre.
    Demarche SF; Schleich FN; Henket MA; Paulus VA; Van Hees TJ; Louis RE
    BMJ Open; 2017 Nov; 7(11):e018186. PubMed ID: 29183929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life.
    Demarche S; Schleich F; Henket M; Paulus V; Louis R; Van Hees T
    Clin Exp Allergy; 2018 May; 48(5):525-535. PubMed ID: 29383782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
    Yin SS; Liu H; Gao X
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function.
    Brooks CR; Van Dalen CJ; Harding E; Hermans IF; Douwes J
    BMC Pulm Med; 2017 Dec; 17(1):169. PubMed ID: 29202821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response.
    Telenga ED; Tideman SW; Kerstjens HA; Hacken NH; Timens W; Postma DS; van den Berge M
    Allergy; 2012 Aug; 67(8):1060-8. PubMed ID: 22686834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of inhaled corticosteroids in patients with controlled asthma: The DISCO (Discontinuation of Inhaled Steroid in Controlled asthmatics Over 6 months) study.
    Kim JH; Jin J; Park SY; Park SY; Kim HJ; Kim MH; Kwon HS; Song WJ; Kim SH; Park HW; Chang YS; Cho YS; Cho YJ; Cho SH; Moon HB; Kim TB
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):123-130.e1. PubMed ID: 33819615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.
    Takahashi K; Meguro K; Kawashima H; Kashiwakuma D; Kagami SI; Ohta S; Ono J; Izuhara K; Iwamoto I
    J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventilation heterogeneity predicts asthma control in adults following inhaled corticosteroid dose titration.
    Farah CS; King GG; Brown NJ; Peters MJ; Berend N; Salome CM
    J Allergy Clin Immunol; 2012 Jul; 130(1):61-8. PubMed ID: 22460065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STOP: an open label crossover trial to study ICS withdrawal in patients with a combination of obesity and low-inflammatory asthma and evaluate its effect on asthma control and quality of life.
    Witte JA; Braunstahl GJ; Blox WJB; van 't Westeinde SC; In 't Veen JCCM; Kappen JH; van Rossum EFC
    BMC Pulm Med; 2022 Feb; 22(1):53. PubMed ID: 35123457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-based asthma phenotypes of corticosteroid response.
    Cowan DC; Taylor DR; Peterson LE; Cowan JO; Palmay R; Williamson A; Hammel J; Erzurum SC; Hazen SL; Comhair SAA
    J Allergy Clin Immunol; 2015 Apr; 135(4):877-883.e1. PubMed ID: 25488689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.
    Fujimoto K; Yamaguchi S; Urushibata K; Hanaoka M; Koizumi T; Honda T; Kubo K
    Intern Med; 2006; 45(14):843-9. PubMed ID: 16908940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients.
    Reid DW; Johns DP; Feltis B; Ward C; Walters EH
    Respirology; 2003 Dec; 8(4):479-86. PubMed ID: 14629652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers for step-down of inhaled corticosteroid therapy in adult asthmatics.
    Tsurikisawa N; Oshikata C; Tsuburai T; Mitsui C; Tanimoto H; Takahashi K; Sekiya K; Nakazawa T; Minoguchi K; Otomo M; Maeda Y; Saito H; Akiyama K
    Allergol Int; 2012 Sep; 61(3):419-29. PubMed ID: 22722811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma.
    Tarodo de la Fuente P; Romagnoli M; Carlsson L; Godard P; Bousquet J; Chanez P
    Respir Med; 1999 Mar; 93(3):183-9. PubMed ID: 10464876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.
    Tomari S; Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Kawano T; Matsuo N; Kohno S
    Respiration; 2008; 76(4):398-402. PubMed ID: 18689991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids.
    Maneechotesuwan K; Supawita S; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ
    J Allergy Clin Immunol; 2008 Jan; 121(1):43-50. PubMed ID: 18036645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.